The Netherlands has ordered an Italian drug maker to cough up nearly 20 million euros ($23.58 million), after the pharma firm inflated the price of one of its medications by an eye-watering 30,000%. In a decision issued on Monday, the Netherlands Authority for Consumers and Markets (ACM) said that the drug manufacturer, Leadiant, had charged “far too high a price” for a prescription medication used in the treatment of patients with a rare hereditary metabolic disorder known as cerebrotendinous xanthomatosis. Around sixty patients in the country suffer from the disorder, which requires life-long treatment, the ACM said in its statement.
Hence then, the article about dutch regulator fines italian pharma firm nearly 20 million euros for hiking drug price by more than 30 000 was published today ( ) and is available onRussia Today ( News ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details Finally We wish PressBee provided you with enough information of ( Dutch regulator fines Italian pharma firm nearly 20 million euros for hiking drug price by more than 30,000% )